Activated Neutrophils Release Mediators That May Contribute to Myocardial Injury and Dysfunction Associated with Ischemia and Reperfusion

Annals of the New York Academy of Sciences

Volumn 524, Issue 1, 1988, Pages 103-121

  MULLANE, KEVIN M ^a,b   WESTLIN, WILLIAM ^a,b   KRAEMER, ROSEMARY ^a,b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA PENTYL 3 (2 QUINOLYLMETHOXY)BENZYL ALCOHOL; ARACHIDONIC ACID; FREE RADICAL; LEUKOTRIENE C4; LEUKOTRIENE D4; LIPOXYGENASE; NAFAZATROM;

ENZYME INHIBITION; HEART INFARCTION SIZE; HEART INJURY; HEART MUSCLE ISCHEMIA; MEDIATOR; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RABBIT; REVIEW;

ARACHIDONIC ACID; ARACHIDONIC ACIDS; BLOOD PLATELETS; CORONARY DISEASE; EICOSANOIC ACIDS; FREE RADICALS; HUMAN; LIPOXYGENASE; MYOCARDIAL DISEASES; NEUTROPHILS; OXYGEN; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION; SEROTONIN; SRS-A; SUPEROXIDES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023713495     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1988.tb38534.x     Document Type: Article

References (86)

1. Progress in autopharmacology. A survey of present knowledge of the chemical regulation of certain functions by natural constituents of the tissues
2. Leukocyte capillary plugging myocardial ischemia and reperfusion in the dog
3. Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti‐inflammatory drugs
4. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium
5. Increased production of arachidonate metabolites in an occlusion‐reperfusion model of canine myocardial infarction
6. Role of oxygen‐derived free radicals and metabolites in leukocyte‐dependent inflammatory reactions
7. Nafazatrom‐induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function
8. Myocardial salvage induced by REV‐5901, an inhibitor and antagonist of the leukotrienes
9. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog
10. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs
11. Granulocytes as active participants in acute myocardial ischemia and infarction
12. Effects of a 5‐lipoxygenase inhibitor (AA‐861) on canine experimental myocardial infarction
13. Canine myocardial reperfusion injury: its reduction by the combined administration of superoxide dismutase and catalase
14. Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury
15. Canine myocardial reperfusion injury: protection by a free radical scavenger, N‐2‐mercaptopropionyl glycine
16. Leukocytes and ischemia‐induced myocardial injury
17. Myocardial ischemia‐reperfusion injury: role of neutrophils and neutrophil derived mediators
18. Release of arachidonate from membrane phospholipids in cultured neonatal rat myocardial cells during adenosine triphosphate depletion
19. 111In‐labelled platelet accumulation in infarcted myocardium
20. Stimulation of leukotriene biosynthesis in human blood leukocytes by platelet‐derived 12‐hydroperoxyeicosatetraenoic acid
21. ω‐Hydroxylation of 12‐R‐hydroxy‐5,8,10,14‐eicosatetraenoic acid in human polymorphonuclear leukocytes
22. Myeloperoxidase‐mediated platelet release reaction
23. Platelet depletion and infarct size in an occlusion‐reperfusion model of myocardial ischemia in anesthetized dogs
24. 4 by transcellular biosynthesis
25. 4 by an enzyme in blood plasma: a possible leukotactic mechanism
26. 4 stimulates polymorphonuclear leukocyte adhesion to cultured endothelial cells
27. The LFA‐1, Mac‐1 glycoprotein family and its deficiency in an inherited disease
28. 4 synthesized by polymorphonuclear leukocytes
29. Granulocyte‐mediated release of histamine from mast cells: effects of myeloperoxidase and its inhibition by anti‐inflammatory sulfone compounds
30. Coronary arteries of cardiac patients are hyperactive and contain stores of amines: a mechanism for coronary spasm
31. Cardiac anaphylaxis: models, mediators, mechanisms, and clinical considerations
32. Resident mononuclear cells participate in myocardial reoxygenation injury
33. Effects of lodoxamide on ischemic reperfused myocardium
34. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats
35. Complement localization and mediation in ischemic injury in baboon myocardium
36. Relationship between 5‐lipoxygenase activity and cellular injury of cardiac myocytes under hypoxia‐reoxygenation
37. Hypoxia provokes release of a neutrophil chemotactic factor from cultured myocardial cells
38. 4 metabolism
39. 4: a potent coronary artery vascoconstrictor assodated with impaired ventricular contraction
40. 4 in the intact pig heart
41. Leukotrienes in myocardial ischemia
42. Effects of endogenously produced leukotrienes, thromboxane, and prostaglandins on coronary vascular resistance in rabbit myocardial infarction
43. 4‐like substance following myocardial infarction in rabbits
44. 4‐like immunoreactive material from cardiac tissue
45. 4 from rat and guinea pig hearts. Evidence that endogenous prostaglandins inhibit leukotriene biosynthesis
46. Exaggerated atrial arachidonate metabolism in rabbit left ventricular myocardial infarction
47. The biologically active leukotrienes
48. 4‐induced coronary constriction at normal and reduced coronary perfusion in dogs
49. Partial purification of a coronary vasodilator released from canine platelets
50. Chemokinetic activity of arachidonic acid lipoxygenase products on leukocytes of different species
51. Unique aspects of the modulation of human neutrophil function by 12‐L‐hydroperoxy‐5,8,10,14‐eicosatetraenoic acid
52. Enhancement of canine collateral flow by nafazatrom
53. 4 is a complete secretagogue in human neutrophils: a kinetic analysis
54. Hydrogen peroxide and hydroxyl radical mediation of cardiac sarcoplasmic reticulum. Participation of cyclooxygenase pathway
55. Influence of oxygen radicals generated by xanthine oxidase in the isolated perfused rat heart
56. Injury to rat hearts produced by an exogenous free radical generating system. Study into the role of arachidonic acid and eicosanoids
57. Hydrogen peroxide and hydroxyl radical mediation of activated neutrophil induced canine myocardial mechanical dysfunction
58. Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline‐perfused rabbit lungs
59. Generation of chemotactic lipid from arachidonic acid by exposure to a superoxide‐generating system
60. 4 in human neutrophils
61. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion
62. Stereochemical difference between 12‐hydroxy‐5,8,10,14‐eicosa‐tetraenoic acid in platelets and psoriatic lesion
63. Chemokinetic activity of 12(S) and 12(R) hydroxyeicosatetraenoic acids from human polymorphonuclear leukocytes
64. Metabolism of arachidonic acid in ionophorestimulated neutrophils. Esterification of a hydroxylated metabolite into phospholipids
65. Recombinant superoxide dismutase reduces oxygen free radical concentrations in reperfused myocardium
66. Spin‐trapping evidence that graded myocardial ischemia alters post‐ischemic superoxide production
67. Myocardial consequences of reperfusion
68. Xanthine oxidase: a critical mediator of myocardial injury during ischemia and reperfusion
69. Inflammation: the role of peroxidase‐derived products
70. Oxygen 18 investigation of the prostaglandin synthetase‐dependent cooxidation of diphenylisobenzofuran
71. Oxygen radicals from arachidonate metabolism in abnormal vascular responses
72. Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias
73. 2 release during coronary occlusion and reperfusion in anesthetized dogs
74. Beneficial actions of a free radical scavenger in traumatic shock and myocardial ischemia
75. Arachidonate metabolism via lipoxygenase and 12‐L‐hydroperoxy‐5,8,10,14‐eicosatetraenoic acid per‐oxidase sensitive to antiinflammatory drugs
76. 4 synthase activities
77. Xanthine oxidase and neutrophil infiltration in intestinal ischemia
78. Myoglobin‐catalyzed hydrogen peroxide dependent arachidonic acid peroxidation
79. Thromboxane synthase as a cytochrome P450 enzyme
80. Comparison of the effects of inhibitors of cytochrome P‐450‐mediated reactions on human platelet aggregation and arachidonic acid metabolism
81. Inhibition of thromboxane synthesis by free radical scavengers